✦ LIBER ✦

Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial

✍ Scribed by Xiaoshun Liu; Yanming Huang; Claude Hanet; Michel Vandormael; Victor Legrand; Joseph Dens; Jean Luc Vandenbossche; Luc Missault; Christiaan Vrints; Ivan De Scheerder

Book ID: 101820634
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 80 KB
Volume: 60
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.10636

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of antirestenosis with the biodivy

Study of antirestenosis with the biodivysio dexamethasone eluting stent (STRIDE): a multicenter trial

✍ Xiaoshun Liu; Yanming Huang; Ivan De Scheerder 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 174 KB

First Results of the DEB-AMI (Drug Eluti

First Results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial: A Multicenter Randomized Comparison of Drug-Eluting Balloon Plus Bare-Metal Stent Versus Bare-Metal Stent Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention With 6-Month Angiographic, Intravascular, Functional, and Clinical Outcomes

✍ Anouar Belkacemi; Pierfrancesco Agostoni; Hendrik M. Nathoe; Michiel Voskuil; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 657 KB

Optimized Duration of Clopidogrel Therap

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

✍ Fausto Feres; Ricardo A. Costa; Deepak L. Bhatt; Martin B. Leon; Roberto V. Bote 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 316 KB

OPTIMIZED DURATION OF CLOPIDOGREL THERAP

OPTIMIZED DURATION OF CLOPIDOGREL THERAPY FOLLOWING TREATMENT WITH THE ENDEAVOR ZOTAROLIMUS-ELUTING STENTS IN THE REAL-WORLD CLINICAL PRACTICE (OPTIMIZE) TRIAL: RATIONALE, DESIGN AND PRELIMINARY RESULTS OF A LARGE-SCALE, RANDOMIZED, MULTICENTER STUDY

✍ Feres, Fausto; Costa, Ricardo A.; Abizaid, Alexandre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 117 KB

A Randomized, Double-Blind, Multicenter

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB